<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-02-04</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-02-04</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>60</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç©ºé—´è½¬å½•ç»„å­¦ä¸å•ç»†èƒæµ‹åºç»“åˆï¼Œæ­ç¤ºäº†Lars2åœ¨å°é¼ å¿ƒè„é‡å¡‘çš„æ—¶ç©ºåŠ¨æ€æœºåˆ¶ï¼›æ•´åˆè‚¿ç˜¤å…ç–«ç»†èƒä¸æŠ—ä½“ç–—æ³•ï¼Œé©±åŠ¨äº†æŠ—è‚¿ç˜¤å…ç–«ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- <strong>è‚¿ç˜¤å…ç–«ä¸æ²»ç–—</strong>ï¼šæ¢ç´¢å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­ç–—æ³•æŠµæŠ—æœºåˆ¶ï¼Œå¼€å‘è‚¿ç˜¤ç‰¹å¼‚æ€§å…ç–«ç»†èƒå’ŒæŠ—ä½“ç–—æ³•ï¼Œä»¥åŠGLIOMBAç­‰è‚¿ç˜¤çš„å…ç–«å¾®ç¯å¢ƒç ”ç©¶ã€‚<br />
- <strong>å…ç–«ç»†èƒåŠŸèƒ½ä¸è°ƒæ§</strong>ï¼šç ”ç©¶TOXå¯¹TH1 CD4+ Tç»†èƒæ•ˆåº”åŠŸèƒ½çš„å½±å“ï¼ŒMHC Iåœ¨CD4+ Tç»†èƒä»‹å¯¼å…ç–«ä¸­çš„ä½œç”¨ï¼Œä»¥åŠIL-22åœ¨3å‹å…ç–«ç»†èƒä¸­çš„é¡ºå¼è°ƒæ§ã€‚<br />
- <strong>ç–¾ç—…æ¨¡å‹ä¸æœºåˆ¶</strong>ï¼šåˆ©ç”¨ç©ºé—´è½¬å½•ç»„å­¦è§£æAPOE4ç­‰åŸºå› åœ¨é˜¿å°”èŒ¨æµ·é»˜ç—…å’Œå¸•é‡‘æ£®ç—…æ¨¡å‹ä¸­çš„ä½œç”¨ï¼Œä»¥åŠå¿ƒè¡€ç®¡ç–¾ç—…ï¼ˆå¦‚å¿ƒè‚Œç—…ã€åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ï¼‰çš„åˆ†å­æœºåˆ¶ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- <strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šç»“åˆç©ºé—´è½¬å½•ç»„å­¦ã€å•ç»†èƒRNAæµ‹åºã€è›‹ç™½ç»„å­¦ç­‰æŠ€æœ¯ï¼Œå®ç°å¯¹å¤æ‚ç”Ÿç‰©è¿‡ç¨‹çš„æ·±åº¦è§£æã€‚<br />
- <strong>æ–°å‹å…ç–«ç–—æ³•ç­–ç•¥</strong>ï¼šé€šè¿‡é¶å‘è¡€ç®¡å¹³æ»‘è‚Œç»†èƒã€è®¾è®¡æ‚åˆèƒ°å²›ç´ è‚½ç­‰ï¼Œæ¢ç´¢æ–°çš„æŠ—è‚¿ç˜¤å’Œè‡ªèº«å…ç–«æ€§ç–¾ç—…æ²»ç–—é€”å¾„ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
SeekGeneæ¨å‡ºé¦–ä¸ªæ•´åˆDNAç”²åŸºåŒ–ã€RNAæµ‹åºä¸å…ç–«è°±ç³»åˆ†æçš„é«˜é€šé‡å•ç»†èƒå¤šç»„å­¦è§£å†³æ–¹æ¡ˆã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢Reelinè›‹ç™½åœ¨ç¼“è§£æ…¢æ€§å‹åŠ›è¯±å¯¼çš„è‚ é“å±éšœæŸä¼¤åŠæŠ‘éƒç—‡ä¸­çš„ä½œç”¨ã€‚<br />
- ä¼˜åŒ–å•ç»†èƒRNAæµ‹åºåˆ†ææ¨¡å‹ï¼Œé€šè¿‡å¼•å…¥å±‚çº§äº¤å‰ç†µæŸå¤±æå‡å¤§è§„æ¨¡ç»†èƒå›¾è°±æ³¨é‡Šç²¾åº¦ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- é¦–æ¬¡å®ç°å•ç»†èƒæ°´å¹³DNAç”²åŸºåŒ–ä¸RNAå¤šç»„å­¦çš„é«˜é€šé‡æ•´åˆåˆ†æã€‚<br />
- æå‡ºåˆ©ç”¨ç”Ÿç‰©å­¦ç»†èƒå±‚çº§å…³ç³»æ”¹è¿›å•ç»†èƒRNAæµ‹åºæ³¨é‡Šæ¨¡å‹ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (57æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE308859 æ•´åˆç©ºé—´è½¬å½•ç»„å­¦å’Œå•ç»†èƒ RNA æµ‹åºæ­ç¤º Lars2 ä»‹å¯¼çš„å°é¼ æ¨ªå‘ä¸»åŠ¨è„‰ç¼©çª„ (TAC) æ¨¡å‹ä¸­å¿ƒè‚Œé‡å¡‘çš„æ—¶ç©ºåŠ¨æ€</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cellã€spatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hanwen Ni ; Feng Liang ; Huanhuan Huo ; Xuechao Feng ; Ben HeSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusMulti-omics approaches have emerged as a cornerstone in medical biology, offering an integrative perspective on tissue and cellular composition, gene expression patterns, functional states, and metabolic dynamics. In this study, we employed multi-omics methodologies, combining spatial transcriptomics (ST) and single-cell RNA sequencing (scRNA-seq), to perform large-scale bioinformatics analysis on heart samples from Transverse Aortic Constriction (TAC) mouse models at various stages of disease progression. The aim was to investigate the spatial and temporal characteristics of cellular distribution, gene composition, and associated functional changes within the myocardium in response to pressure overload. For the first time, the pathophysiology of myocardial hypertrophy in this model is described through the integrated lens of spatial and single-cell transcriptomics. The spatial transcriptomics analysis revealed a uniform cellular distribution across the heart tissue in TAC mice at different disease stages. However, substantial shifts in cellular composition were observed, with the most significant alterations occurring in cluster 1, which primarily involved changes in fibroblasts and macrophages. Single-cell RNA sequencing further demonstrated that the most notable changes in cellular composition occurred at the TAC-4W stage, characterized by a reduction in fibroblast and macrophage populations and an increase in immune cell subsets, such as neutrophils and T cells. By TAC-6W, the cellular composition returned to a state comparable to that observed at TAC-2W. Further analysis integrating both spatial and single-cell transcriptomes highlighted cluster 1 as the site of the most prominent microenvironmental changes, predominantly involving T cells and macrophages. Notably, the genes Lef1, Ccr7, Sell, and Lars2 were identified as significantly differentially expressed in these cellsâ€”an observation not previously reported. In particular, the expression of Lars2 exhibited dynamic modulation throughout disease progression. While its expression at TAC-2W did not differ significantly from controls, Lars2 expression peaked at TAC-4W, only to decline at TAC-6W. This study provides a comprehensive characterization of myocardial hypertrophy in the TAC mouse model, leveraging the power of spatial trans...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308859" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE302765 è‚¿ç˜¤ç‰¹å¼‚æ€§æ ‘çªçŠ¶ç»†èƒå’ŒæŠ—ä½“ç–—æ³•åœ¨è‚¿ç˜¤å†…çš„æ•´åˆé©±åŠ¨å…ˆå¤©æ€§å’Œé€‚åº”æ€§æŠ—ç™Œå…ç–« [PanCancer_IO360_NanoString]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€dendritic cellã€antibody<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Saurabh Garg ; Brian CzernieckiSeries Type : Expression profiling by arrayOrganism : Mus musculusComparison of gene expression profiles of HER2+ murine mammary carcinoma treated with HER2 DC1, anti-Sema4D, and combination of both HER2 DC1 and anti-Sema4D therapy<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302765" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE302764 è‚¿ç˜¤ç‰¹å¼‚æ€§æ ‘çªçŠ¶ç»†èƒå’ŒæŠ—ä½“ç–—æ³•åœ¨è‚¿ç˜¤å†…çš„æ•´åˆé©±åŠ¨å…ˆå¤©æ€§å’Œé€‚åº”æ€§æŠ—ç™Œå…ç–« [Immunology_NanoString]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€dendritic cellã€antibody<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Saurabh Garg ; Brian CzernieckiSeries Type : Expression profiling by arrayOrganism : Mus musculusComparison of gene expression profiles of HER2+ murine mammary carcinoma treated with HER2 DC1, anti-Sema4D, and combination of both HER2 DC1 and anti-Sema4D therapy<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302764" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE302763 è‚¿ç˜¤ç‰¹å¼‚æ€§æ ‘çªçŠ¶ç»†èƒå’ŒæŠ—ä½“ç–—æ³•åœ¨è‚¿ç˜¤å†…çš„æ•´åˆé©±åŠ¨å…ˆå¤©æ€§å’Œé€‚åº”æ€§æŠ—ç™Œå…ç–« [Myeloid_Innate_Immunity_NanoString]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€dendritic cellã€antibody<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Saurabh Garg ; Brian CzernieckiSeries Type : Expression profiling by arrayOrganism : Mus musculusComparison of gene expression profiles of HER2+ murine mammary carcinoma treated with HER2 DC1, anti-Sema4D, and combination of both HER2 DC1 and anti-Sema4D therapy<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302763" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE302735 è‚¿ç˜¤ç‰¹å¼‚æ€§æ ‘çªçŠ¶ç»†èƒå’ŒæŠ—ä½“ç–—æ³•åœ¨è‚¿ç˜¤å†…çš„æ•´åˆé©±åŠ¨å…ˆå¤©æ€§å’Œé€‚åº”æ€§æŠ—ç™Œå…ç–« [Metabolic_Pathways_NanoString]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€dendritic cellã€antibody<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Garg Saurabh ; Czerniecki BrianSeries Type : Expression profiling by arrayOrganism : Mus musculusComparison of gene expression profiles of HER2+ murine mammary carcinoma treated with HER2 DC1, anti-Sema4D, and combination of both HER2 DC1 and anti-Sema4D therapy<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302735" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE317909 TOX é©±åŠ¨ TH1 CD4+ T ç»†èƒæ•ˆåº”åŠŸèƒ½ã€æŠ—è‚¿ç˜¤å…ç–«å’Œè‡ªèº«å…ç–«æ€§ç–¾ç—…çš„è‡´ç—…æ€§ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Andrea Schietinger ; Brianna Naizir ; Andrew Scott ; Doron Betel ; Paul ZumboSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusRNA-seq analysis of TOX WT and TOX KO transgenic (TCRSMARTA) CD4 T cells from tdLN of tumor-bearing mice day 11 post transfer<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317909" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE301073 ä¸åŒçš„è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒ (TIME) ç‰¹å¾é©±åŠ¨èƒ¶è´¨æ¯ç»†èƒç˜¤ä¸­ä¸åŒçš„å…ç–«æ²»ç–—ååº”</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€regex:immuno(logy|therapy|suppression)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Linqian Weng ; Krish Skandha Gopalan ; Gabriele BergersSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusGlioblastoma (GBM) exhibits significant molecular heterogeneity leading to variable treatment responses. Despite multimodal therapies, prognosis remains poor, highlighting the need for personalized approaches targeting the tumor immune microenvironment (TIME). Using single-cell RNA sequencing, multiplex immunohistochemistry, and orthotopic mouse models, we characterized distinct TIME subtypes and evaluated responses to anti-angiogenic immunotherapy and myeloid-targeting approaches. We identified three TIME subtypes: TIME-low (immune-excluded with abnormal vasculature), TIME-med (immune-infiltrated with functional T cells), and TIME-high (heavily infiltrated with immunosuppressive myeloid cells and anergic T cells). TIME-low GBMs responded transiently to anti-angiogenic immunotherapy with immunostimulatory T cell shifts, while anti-angiogenic therapy was ineffective in TIME-high GBMs due to immunosuppressive myeloid cells. CD40 agonist treatment worsened outcomes in TIME-high GBMs by increasing immunosuppressive cells and reducing NK recruitment. Conversely, PI3KÎ³/Î´ inhibition combined with anti-angiogenic immunotherapy modestly extended survival in TIME-high tumors. Our study reveals that GBM subtypes require tailored therapeutic strategies, with TIME classification potentially predicting treatment responses and TIME-high tumors requiring myeloid reprogramming to overcome immunosuppression.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301073" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE273583 è½¬ç§»æ€§é»‘è‰²ç´ ç˜¤å¯¹å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­ç–—æ³•çš„å…ˆå¤©æ€§å’Œè·å¾—æ€§è€è¯æ€§çš„ç»¼åˆè›‹ç™½è´¨åŸºå› ç»„å­¦å’Œç©ºé—´åˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€resistanceã€spatial<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Shiyou wei ; Kuang Du ; Hongbin Lan ; Zhenyu Yang ; Yulan Deng ; Zhi Wek ; Dennie T Frederick ; Jinho Lee ; Marilyne Labrie ; Tian Tian ; Tabea Moll ; Yeqing Chen ; Ryan J Sullivan ; Gordon Mills ; Genevieve M Boland ; Keith T Flaherty ; Lunxu Liu ; Meenhard Herlyn ; Gao ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensWhile a subset of patients with metastatic melanoma achieves durable responses to immune checkpoint blockade (ICB) therapies, the majority ultimately exhibit either innate or acquired resistance to these treatments. However, the molecular mechanisms underlying resistance to ICB therapies remain elusive and are warranted to elucidate. Here, we comprehensively investigated the tumor and tumor immune microenvironment (TIME) of paired pre- and post-treatment tumor specimens from metastatic melanoma patients who were primary or secondary resistance to anti-CTLA-4 and/or anti-PD-1/PD-L1 therapies. Differentially expressed gene (DEG) analysis and single-sample gene set enrichment analysis (ssGSEA) with transcriptomic data identified cell cycle and c-MYC signaling as pathway-based resistance signatures. And weighted gene co-expression network analysis (WGCNA) revealed the activation of a cross-resistance meta-program involving key signaling pathways related to tumor progression in ICB resistant melanoma. Moreover, spatially-resolved, image-based immune monitoring analysis by using NanoStringâ€™s digital spatial profiling (DSP) and Cyclic Immunofluorescence (CyCIF) showed infiltration of suppressive immune cells in the tumor microenvironment of melanoma with resistance to ICB therapies. Our study reveals the molecular mechanisms underlying resistance to ICB therapies in patients with metastatic melanoma by conducting such integrated analyses of multi-dimensional data, and provides rationale for salvage therapies that will potentially overcome resistance to ICB therapies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273583" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE317910 TOX é©±åŠ¨ TH1 CD4+ T ç»†èƒæ•ˆåº”åŠŸèƒ½ã€æŠ—è‚¿ç˜¤å…ç–«å’Œè‡ªèº«å…ç–«æ€§ç–¾ç—…çš„è‡´ç—…æ€§ [CUT&amp;RUN]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Simon Grassmann ; Brianna Naizir ; Paul Zumbo ; Doron Betel ; Andrea SchietingerSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusCUT&amp;RUN analysis of CD4 and CD8 T cells (confirmed to express TOX)<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317910" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE317904 TOX é©±åŠ¨ TH1 CD4+ T ç»†èƒæ•ˆåº”åŠŸèƒ½ã€æŠ—è‚¿ç˜¤å…ç–«ä»¥åŠè‡ªèº«å…ç–«æ€§ç–¾ç—…çš„è‡´ç—…æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Andrea Schietinger ; Brianna Naizir ; Andrew Scott ; Doron Betel ; Paul ZumboSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusATAC-seq analysis of TOX WT and TOX KO transgenic (TCRSMARTA) CD4 T cells from tdLN of tumor-bearing mice at day 11 post transfer<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317904" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 47 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>SeekGeneæ¨å‡ºé«˜é€šé‡å•ç»†èƒDNAç”²åŸºåŒ–+RNAå¤šç»„å­¦è§£å†³æ–¹æ¡ˆ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cellã€methylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeekGene unveiled a high-throughput single-cell platform that integrates RNA sequencing with DNA methylation and immune profiling..<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/seekgene-launches-high-throughput-single-cell-dna-methylation-rna-multi-omics-solution/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>ç§‘å­¦å®¶å‘ç°ä¸€ç§è›‹ç™½è´¨ï¼Œå®ƒèƒ½ä¿®å¤è‚ æ¼å¹¶ç¼“è§£æŠ‘éƒç—‡ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šChronic stress can damage the gutâ€™s protective lining, triggering inflammation that may worsen depression. New research shows that stress lowers levels of a protein called Reelin, which plays a key role in both gut repair and brain health. Remarkably, a single injection restored Reelin levels and produced antidepressant-like effects in preclinical models. The findings hint at a future treatment that targets depression through the gutâ€“brain connection.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260201231240.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>åˆ©ç”¨åˆ†å±‚äº¤å‰ç†µæŸå¤±æ”¹è¿›å›¾è°±å°ºåº¦å•ç»†èƒæ³¨é‡Šæ¨¡å‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA new approach to RNA sequencing analysis shows that respecting biological cell hierarchies improves single-cell annotation accuracy, especially when models are applied to new...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/improving-atlas-scale-single-cell-annotation-models-with-hierarchical-cross-entropy-loss/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>tumor</td>
<td>13</td>
</tr>
<tr>
<td>regex:immuno(logy</td>
<td>therapy</td>
</tr>
<tr>
<td>cancer</td>
<td>9</td>
</tr>
<tr>
<td>immunity</td>
<td>8</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>8</td>
</tr>
<tr>
<td>immune</td>
<td>7</td>
</tr>
<tr>
<td>T cell</td>
<td>6</td>
</tr>
<tr>
<td>single-cell</td>
<td>4</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>4</td>
</tr>
<tr>
<td>genome</td>
<td>4</td>
</tr>
<tr>
<td>dendritic cell</td>
<td>4</td>
</tr>
<tr>
<td>antibody</td>
<td>4</td>
</tr>
<tr>
<td>spatial</td>
<td>3</td>
</tr>
<tr>
<td>sequencing</td>
<td>2</td>
</tr>
<tr>
<td>spatial transcriptomics</td>
<td>2</td>
</tr>
<tr>
<td>histone</td>
<td>2</td>
</tr>
<tr>
<td>Hi-C</td>
<td>2</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>2</td>
</tr>
<tr>
<td>scRNA</td>
<td>2</td>
</tr>
<tr>
<td>tumor microenvironment</td>
<td>2</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (47æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316959" target="_blank" rel="noopener noreferrer">GSE316959 é¶ç»†èƒä¸Šçš„ MHC I ç±»åˆ†å­è°ƒèŠ‚ CD4+ T ç»†èƒä»‹å¯¼çš„å…ç–«</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299087" target="_blank" rel="noopener noreferrer">GSE299087 æŠ—åŸç‰¹å¼‚æ€§å…ç–«ç–—æ³•åˆ©ç”¨CD4æ‚äº¤èƒ°å²›ç´ è‚½æ–°è¡¨ä½æŠ‘åˆ¶èƒ°å²›ç§»æ¤ä¸­CD8 Tç»†èƒçš„åˆ†åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293896" target="_blank" rel="noopener noreferrer">GSE293896 ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤º APOE4 ç­‰ä½åŸºå› å¯¹è·¯æ˜“ä½“ç—´å‘†ä¸­ Î±-çªè§¦æ ¸è›‹ç™½èšé›†å’Œç»†èƒé—´é€šè®¯çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308355" target="_blank" rel="noopener noreferrer">GSE308355 CLK1 é€šè¿‡æ¿€æ´» Hippo/YAP ä¿¡å·é€šè·¯ä¿ƒè¿› MDSC è¿ç§»å¹¶é‡ç¼–ç¨‹ç»“ç›´è‚ ç™Œè‚¿ç˜¤å¾®ç¯å¢ƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308264" target="_blank" rel="noopener noreferrer">GSE308264ï¼šRettç»¼åˆå¾iPSç»†èƒä¸­ç»„è›‹ç™½ä¿®é¥°H3K27acå’ŒCTCFè½¬å½•å› å­ç»“åˆçš„å…¨åŸºå› ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE246314" target="_blank" rel="noopener noreferrer">GSE246314 HEK293ç»†èƒç»VPAå¤„ç†åç»„è›‹ç™½ä¿®é¥°H3K27acå’ŒCTCFè½¬å½•å› å­ç»“åˆçš„å…¨åŸºå› ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245856" target="_blank" rel="noopener noreferrer">GSE245856 HEK293ç»†èƒç»VPAå¤„ç†åé‡‡ç”¨RNA-seqè¿›è¡Œå…¨åŸºå› ç»„åŸºå› è¡¨è¾¾è°±åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245848" target="_blank" rel="noopener noreferrer">GSE245848 HEK293ç»†èƒç»VPAå¤„ç†åï¼Œåˆ©ç”¨Hi-Cè¿›è¡Œå…¨åŸºå› ç»„æŸ“è‰²è´¨ç›¸äº’ä½œç”¨åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314572" target="_blank" rel="noopener noreferrer">GSE314572 3å‹å…ç–«ç»†èƒä¸­IL-22åŸºå› çš„é¡ºå¼è°ƒæ§[RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314555" target="_blank" rel="noopener noreferrer">GSE314555 IL-22 åŸºå› åœ¨ 3 å‹å…ç–«ç»†èƒä¸­çš„é¡ºå¼è°ƒæ§ [Chip-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314539" target="_blank" rel="noopener noreferrer">GSE314539 IL-22 åŸºå› åœ¨ 3 å‹å…ç–«ç»†èƒä¸­çš„é¡ºå¼è°ƒæ§ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE240148" target="_blank" rel="noopener noreferrer">GSE240148 å°é¼ ä½“å†…ç§»æ¤çš„B2M KO CD40å¤„ç†çš„B16è‚¿ç˜¤ä¸­è‚¿ç˜¤å¾®ç¯å¢ƒçš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314851" target="_blank" rel="noopener noreferrer">GSE314851 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [Visium]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317742" target="_blank" rel="noopener noreferrer">GSE317742 ä»è‚¿ç˜¤éƒ¨ä½è¿ç§»åˆ°èƒ¸è…ºçš„æ ‘çªçŠ¶ç»†èƒçš„ç‰¹å¾åˆ†æ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302512" target="_blank" rel="noopener noreferrer">GSE302512 Tç»†èƒè¡ç”Ÿçš„TNFé©±åŠ¨å¿ƒè‚Œç‚ï¼Œä½†å¯¹æ£€æŸ¥ç‚¹å…ç–«ç–—æ³•çš„æŠ—è‚¿ç˜¤ç–—æ•ˆå¹¶éå¿…éœ€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293887" target="_blank" rel="noopener noreferrer">GSE293887 é«˜çº§åˆ«æµ†æ¶²æ€§åµå·¢ç™Œå¾®ç¯å¢ƒçš„3Däº”é‡åŸ¹å…»æ¨¡å‹è½¬å½•ç»„å­¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318176" target="_blank" rel="noopener noreferrer">GSE318176 å¯¹ä¸åŒ SARS-CoV-2 ç–«è‹—æ¥ç§è€…å¤–å‘¨è¡€çš„æ•´åˆè¡¨è§‚åŸºå› ç»„å­¦å’Œè½¬å½•ç»„å­¦åˆ†ææ­ç¤ºäº† TGF-Î² ä»‹å¯¼çš„è€—ç«­æœºåˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317457" target="_blank" rel="noopener noreferrer">GSE317457 ç³–åŸºåŒ–GM-CSFæ‰©å¢B-1bç»†èƒå’ŒB-1bæµ†ç»†èƒå¹¶ä½¿å…¶äº§ç”Ÿå…ç–«æŠ‘åˆ¶ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316800" target="_blank" rel="noopener noreferrer">GSE316800 æ‹‰ä¼¸é€šè¿‡ç›´æ¥æœºæ¢°æ•ˆåº”æŠ‘åˆ¶MMTV-PYMTä¸­çš„è‚¿ç˜¤ç”Ÿé•¿</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316197" target="_blank" rel="noopener noreferrer">GSE316197 NanoString ä¹³è…ºç™Œ 360 è¡¨è¾¾è°±åˆ†æï¼Œæ¥è‡ª NHBW å’Œ NHWW ä¾›ä½“çš„ç»„ç»‡å­¦æ­£å¸¸ä¹³è…ºå°å¶ (BC360)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299250" target="_blank" rel="noopener noreferrer">GSE299250 L1CAM é€šè¿‡ NF-ÎºB æ¿€æ´»ä¿ƒè¿›äººç±»å­å®«å†…è†œç™Œçš„å‘ç”Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294707" target="_blank" rel="noopener noreferrer">GSE294707 æ¶ˆé™¤ DGCR8 è¡¨è¾¾å¯¹èƒšèƒç•¸èƒç˜¤ PA-1 ç»†èƒç¨³æ€ RNA æ°´å¹³çš„å½±å“ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314554" target="_blank" rel="noopener noreferrer">GSE314554 3 å‹å…ç–«ç»†èƒä¸­ IL-22 åŸºå› çš„é¡ºå¼è°ƒæ§ [ATAC-seq_Mnk3]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314532" target="_blank" rel="noopener noreferrer">GSE314532 3å‹å…ç–«ç»†èƒä¸­IL-22åŸºå› çš„é¡ºå¼è°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314278" target="_blank" rel="noopener noreferrer">GSE314278 åˆ©ç”¨æ–°å‹é€šç”¨Î³é“¾ç»†èƒå› å­èåˆåˆ†å­æ²»ç–—ç”ŸæˆæŒä¹…æ€§HIV CAR-TSCMç»†èƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314231" target="_blank" rel="noopener noreferrer">GSE314231 åŒ–ç–—è¯±å¯¼çš„ååº”æ€§é«“ç³»é€ è¡€å¯¼è‡´å°é¼ å’Œäººç±»å…ç–«æŠ‘åˆ¶æ€§ä¸­æ€§ç²’ç»†èƒæ ·å•æ ¸ç»†èƒæ‰©å¢ [scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314047" target="_blank" rel="noopener noreferrer">GSE314047 åŒ–ç–—è¯±å¯¼çš„ååº”æ€§é«“ç³»é€ è¡€å¯¼è‡´å°é¼ å’Œäººç±»å…ç–«æŠ‘åˆ¶æ€§ä¸­æ€§ç²’ç»†èƒæ ·å•æ ¸ç»†èƒçš„æ‰©å¢ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304626" target="_blank" rel="noopener noreferrer">GSE304626 CXCL10/CXCR3è½´å¯¹äºç»´æŒä¸‰é˜´æ€§ä¹³è…ºç™Œçš„å…ç–«ä¼‘çœ è‡³å…³é‡è¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291577" target="_blank" rel="noopener noreferrer">GSE291577 èŠ±ç²‰å‘è‚²ä¸­å…·æœ‰åŠŸèƒ½ä½œç”¨çš„siRNAçš„é•¿è·ç¦»è¿è¾“[RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289883" target="_blank" rel="noopener noreferrer">è‚ºç§»æ¤å°é¼ çš„GSE289883å•ç»†èƒRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315740" target="_blank" rel="noopener noreferrer">GSE315740 æœ‰æ°§è¿åŠ¨å¯¹æ…¢æ€§åº”æ¿€è¯±å¯¼çš„é’å°‘å¹´å°é¼ æŠ‘éƒæ ·è¡Œä¸ºå’Œæµ·é©¬è½¬å½•ç»„çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315736" target="_blank" rel="noopener noreferrer">GSE315736 PTP1BæŠ‘åˆ¶é€šè¿‡å¢å¼ºSYKä¿¡å·ä¼ å¯¼ä¿ƒè¿›é˜¿å°”èŒ¨æµ·é»˜ç—…æ¨¡å‹ä¸­çš„å°èƒ¶è´¨ç»†èƒåå™¬ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315246" target="_blank" rel="noopener noreferrer">GSE315246 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [Xenium åŸä½]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314854" target="_blank" rel="noopener noreferrer">GSE314854 é€šè¿‡FAPé¶å‘å…ç–«ç–—æ³•æ²»ç–—åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314600" target="_blank" rel="noopener noreferrer">GSE314600 é€šè¿‡FAPé¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [SMC_Foam_Cell]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314598" target="_blank" rel="noopener noreferrer">GSE314598 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [å°é¼ ä¸»åŠ¨è„‰ BiTE]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314596" target="_blank" rel="noopener noreferrer">GSE314596 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [Human_CITEseq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314595" target="_blank" rel="noopener noreferrer">GSE314595 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [Foam_Cell]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306867" target="_blank" rel="noopener noreferrer">GSE306867 PAR1æ¿€é…¶å®¶æ—çš„ä¸¤ä¸ªæˆå‘˜PAR1bå’ŒPAR1aä¹‹é—´å­˜åœ¨éšæ€§å†—ä½™ï¼Œè¿™ç§å†—ä½™ä¸PAR1bæ•²é™¤å°é¼ çš„å­˜æ´»æœ‰å…³</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200898" target="_blank" rel="noopener noreferrer">GSE200898 å°é¼ æ»‘è†œå•ç»†èƒRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200283" target="_blank" rel="noopener noreferrer">GSE200283 å°é¼ æ»‘è†œæ‰¹é‡ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318090" target="_blank" rel="noopener noreferrer">GSE318090 Functional architecture of cardiac TF regulatory landscapes in control of mammalian heart development</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318002" target="_blank" rel="noopener noreferrer">GSE318002 å•ç»†èƒåˆ†è¾¨ç‡ä¸‹å‘è‚²ä¸­é¸¡ä¸‰å‰ç¥ç»èŠ‚çš„ç»†èƒå¤šæ ·æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317933" target="_blank" rel="noopener noreferrer">GSE317933 è‹¦å‚è‹·é€šè¿‡é¶å‘DDX5/c-Mycè½´æŠ‘åˆ¶è›‹ç™½è´¨åˆæˆæ¥æŠ‘åˆ¶æ€¥æ€§é«“ç³»ç™½è¡€ç—…</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317744" target="_blank" rel="noopener noreferrer">GSE317744 èƒ¸è…º CD11c+ ç»†èƒ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289429" target="_blank" rel="noopener noreferrer">GSE289429 è‚¿ç˜¤æŠ‘åˆ¶å› å­ STAG2 ä¸ DREAM ååŒä½œç”¨ï¼Œç»´æŒå°¿è·¯ä¸Šçš®çš„é™æ­¢çŠ¶æ€ [Hi-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288712" target="_blank" rel="noopener noreferrer">GSE288712 è‚¿ç˜¤æŠ‘åˆ¶å› å­STAG2ä¸DREAMååŒä½œç”¨ï¼Œç»´æŒå°¿è·¯ä¸Šçš®ç»†èƒçš„é™æ­¢çŠ¶æ€ã€‚</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-03 21:53</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>